Termination by Amgen a. If the ***** has not been identified, as that research milestone is defined in Section 8.4.a., on or before ***** months from the Effective Date, Amgen may, at its option, provide written notice of termination to GENE at any time thereafter until such time as the ***** is identified or Amgen elects to advance the Research Program to the ***** of the Research Plan pursuant to Section 8.4.a., and the Agreement shall automatically terminate ***** days after such prior written notice of termination is provided to GENE.
Termination by Amgen. Amgen may terminate this Agreement, with or without cause, effective on January 1 of any year after January 1, 1999, with at least [ * ] days prior written notice; provided, however, that Amgen may also terminate this Agreement if Caliper has not delivered within [ * ] days of the end of the [ * ] quarter of [ * ] the Multi Sipper Instrument scheduled to be delivered that quarter by providing Caliper with written notice at any time prior to the expiration of the extended term of the 1999 subscription described in Section 2.2. All rights and obligations applicable under this Agreement through the effective date of termination shall continue to apply until such date irrespective of any delivery of notice of termination, including but not limited to [ * ].
Termination by Amgen. Amgen may terminate this Agreement in its entirety at any time and for any reason or for no reason upon delivery of (i) at least [***] prior written notice to Arrowhead if no First Commercial Sale has occurred with respect to a Licensed Product and (ii) 38. . Confidential at least [***] prior written notice to Arrowhead if First Commercial Sale has occurred with respect to a Licensed Product.
Termination by Amgen. In the event Hyseq shall not timely [***] pursuant to either Section 10.4(c)(i) or 10.4(c)(ii) or shall not timely administer a Licensed Product to a patient pursuant to Section 10.4(c)(iii), Amgen shall have the sole right to terminate this License Agreement by providing [***] prior written notification of termination to Hyseq.
Termination by Amgen. Subject to any termination obligations set forth in 15.4.2 (Termination Effects), Amgen may terminate this Agreement in its entirety upon [***] months prior written notice (or, after First Commercial Sale of a Product, [***] months’ prior written notice) to KKC.
Termination by Amgen. In the event Hyseq shall not [***] pursuant to either Section 13.3(c)(i) or 13.3(c)(ii) or shall not timely administer a Collaboration Product to a patient pursuant to Section 13.3(c)(iii), Amgen shall have the right, in its sole discretion, to terminate this Agreement by providing [***] prior written notification of termination to Hyseq. The effects of such termination will occur in accordance with Section [***].
Termination by Amgen. Amgen will have the right to terminate this Agreement in its entirety at any time upon ninety (90) days’ prior written notice to TScan.
Termination by Amgen. In the event Hyseq shall not timely pay any maintenance fees due pursuant to either Section 13.3(c)(i) or 13.3(c)(ii) or shall not timely administer a Collaboration Product to a patient pursuant to Section 13.3(c)(iii), Amgen shall have the right, in its sole discretion, to terminate this Agreement by providing thirty (30) days prior written notification of termination to Hyseq. The effects of such termination will occur in accordance with Section 16.9(a).
Termination by Amgen. In the event Nuvelo shall not timely pay any maintenance fees due pursuant to either Section 10.4(c)(i) or 10.4(c)(ii) or shall not timely administer a Licensed Product to a patient pursuant to Section 10.4(c)(iii), Amgen shall have the sole right to terminate this License Agreement by providing thirty (30) days prior written notification of termination to Nuvelo.
Termination by Amgen
